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A new great wall: commissioning a new hospital in China
A nationwide healthcare reform in China began in 2009, when 
the government injected GBP 85 billion to improve the healthcare 
coverage for its 1.3 billion population. Healthcare in China is 
primarily a market-based system, driven principally by demand, 
but the necessary supervision is relatively ineffective. There is 
a lack of trust between patients, who act as paying clients, and 
doctors, who often put the institution ﬁ rst, leading to frequent 
medical disputes. The University of Hong Kong Shenzhen 
Hospital is a joint venture between the city of Shenzhen and the 
University, with the mission to provide a new healthcare model in 
China. A clear process is in place to improve the clinical standard 
while a clean governance structure is set up. The hospital has 
ushered in many new initiatives. It is hoped that these will serve 
as a model for healthcare reform in China.
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Introduction
In China, a nationwide health care reform has been underway 
since 20091–4 in an attempt to modernise a publicly funded 
‘grass-roots’ basic service amid much public discontent.5 
Funded through a budget of GBP 85 billion, equal access is to 
be achieved by 2012 and universal coverage by 2020. The new 
University of Hong Kong Shenzhen Hospital (HKU-SZH) is 
a part of this evolution, representing a joint venture between 
the University of Hong Kong (HKU) and the municipal city 
of Shenzhen (SZ). This entirely new healthcare model aims to 
represent the best international standards and the strongest 
areas of Chinese healthcare, while ensuring cultural, social and 
political acceptability to the city and its people. 
The principles of HKU-SZH are very much in line with 
those of the NHS: putting patients at the centre of attention, 
providing high quality treatment, offering a transparent, 
responsible, caring and clean structure of governance, 
informing patients, and developing and supporting staff. In 
this article, we will describe the challenges and the progress we 
have made in our hospital over the last two years. Despite the 
diffi culties and problems confronting Chinese healthcare, staff 
at the HKU-SZH have an immense commitment to working 
together to provide their patients with up-to-date and better 
healthcare. It is hoped that this new model of healthcare – ie 
promoting positive understanding and empathy between the 
public and the healthcare workers, with emphasis on clinical 
cost effectiveness, credibility, provision of training, research 
opportunities, job satisfaction and respect, supported by a 
responsible structure of governance – will enable the joint 
venture to succeed and realise its aims and aspirations.
A brief overview of the city of Shenzhen
Shenzhen is the fourth largest city in China,6 with a GDP of 
over GBP 135 billion. The city is 35 km north of Hong Kong, 
separated by the Shenzhen river. The city was designated as a 
Special Economic Zone in 1980 when China launched the fi rst 
phase of its modernisation and economic reform programme. 
The estimated population of what was then regarded as a 
fi shing port was reported to be about 30,000. Since then, the 
population has undergone exponential growth. By 2010, the 
population reached 10,357,938, 90% of whom were migrants. 
They were young, with an average age of below 30, and well 
educated (1,779,018 college-educated, 2,482,326 high-school-
educated, 4,562,697 educated to junior high level and 920,124 
to primary level, according to 2011 Shenzhen municipal 
statistics). These vibrant human resources helped to lay the 
strong foundation on which the economic success of the city 
is built. The city started its development initially as major 
manufacturing centre and is now becoming one of the leading 
centres of information technology innovation, software 
development and fi nancial services in China, and is now home 
to one of the biggest biotech company in the world.7,8
A brief overview of the healthcare system debate in 
China
The provision of good, safe, effective and comprehensive 
healthcare has long been regarded as a holy grail for the leaders of 
any country. It generates intense debate, the spectrum of which 
can vary from one of emotional and ideological engagement to 
detached analysis based solely on socioeconomic considerations. 
Specifi cally, the optimal means of funding such provision is 
unclear, as costs escalate at a rate that far exceeds the average 
growth of GDP in any country, even one growing as fast as China. 
The Future Hospital Commission of the RCP9 highlighted 
some of the changes needed if the NHS is to cope with 
increasing demands from patients, escalating medical costs 
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and the aspirations of its workforce. In China, healthcare 
reforms are if anything even more hotly debated, especially 
against the background of its impressive and unrivalled 
economic achievements since 1979,2–5 which have bestowed an 
unprecedented improvement in living standards. By contrast, 
the availability of adequate healthcare has been fragmented 
and can vary widely from city to city, province to province, and 
above all from the urban to rural environment.4 At its core, 
the problem lies in the systems of funding employed. Prior to 
1979, a Maoist model in which the state controlled both the 
demand for, and supply of, healthcare was in place. Since 1979, 
economic and political reforms have seen the setting up of a 
market-driven model where the allocation of resources is based 
on free market principles,10 although mainly embracing the 
concept of payment for items (but not services). On the positive 
side, this transformation resulted in a general improvement of 
standards of healthcare. However, given that China, by her own 
admission, is still a developing country, the application of free 
market principles has led to different people receiving different 
treatment, depending both on the ability to pay and geographical 
area. This has led to widespread public discontent. As a result, in 
2009, the State Department launched an ambitious programme 
of reform,10,11 including universal insurance coverage,12 which 
will be discussed in subsequent sections of this paper. 
Funding models of healthcare in China and their 
associated problems
In China public hospitals receive 87.6% of the total funding2 
for medical care and therefore have market dominance. Thus, 
some 85% of beds are in public hospitals. However, the overall 
budget is generally regarded as grossly insuffi cient. Hospitals 
are also handicapped by supervision and control issues, 
impacting adversely on effi ciency and quality. In general, the 
average funding supplied by the government for any public 
hospital is about 15% of its revenue and this is often targeted 
towards capital projects, leaving 85% of its operating budget 
reliant on its own sources of fi nance. 
Under the present healthcare system, effective supervision is 
absent. Clinical services are provided on the basis of market 
demand for what are often ‘trendy’ medicines, rather than 
evidence-based care determined according to clinical need. 
Hospitals function publicly as clinical business units, which 
has led to over-prescription, over-treatment, over-investigation, 
over-regulation, favouritism, infl uence-peddling, corruption, 
shopping around, wasting of resources, medical disputes and 
even physical violence (see below). 
Second, the pricing of medical services and the salaries of 
doctors have been set at a very low level, driving some to seek 
‘grey’ income based on commissions for drug prescription, 
and so-called ‘red packets of cash’ for services provided. Such 
distorted behaviour and perverse incentives may lead to doctors 
becoming ‘salesmen’ for specifi c clinical services.13 
Third, the allocation of medical resources and talents is 
largely channelled towards public hospitals, resulting in a weak 
system of primary care, especially in rural areas. Even in a well-
established and modern metropolis like Shenzhen, there is a lack 
of primary care, leading to the inappropriate use of secondary 
care resources, and a draining effect on specialist expertise. 
Fourth, regulations intended to improve clinical safety 
through the imposition of minimum standards (a necessary 
and rational development for China, with its large territories 
and widely differing levels of healthcare access among its cities, 
provinces and regions) have been over-ambitious and often 
poorly defi ned, understood and applied; arguably they have 
deterred innovation and restricted fl exibility. For instance, the 
setup of a MR/CT scan needs four separate application processes 
and licenses. A cardiologist wishing to pursue interventional 
cardiology requires a license to do so, but it is unclear where or 
when the next license application or examination process will 
take place. This is also refl ected in a lack of standardisation in 
postgraduate medical training on a national and even provincial 
basis. However, early reforms and pioneering work by some 
leading medical schools have already led to more structured and 
standardised undergraduate training; the challenge of extending 
these to postgraduate study remains.14,15
Finally, incidents in which disgruntled patients or relatives 
carry out acts of verbal or physical violence against medical or 
nursing staff are common in hospitals. Weapons may be used 
and fatalities have been reported.16,17 This is a phenomenon 
unique to China that generates widespread national and 
international attention.18 The reasons for such acts are varied 
and multifactorial, but refl ect an underlying and deep-rooted 
lack of trust between patients and healthcare providers. Poor 
communication, lack of consultation time and unrealistic 
expectations that remuneration must lead to speedy diagnosis 
and treatment and then to full, prompt and perfect recovery 
from the illness have been roots of these problems. When 
these expectations fail to materialise, grievances, accusations, 
disputes, confrontations and even violence from the patients, 
their families and friends follow as a result in many cases. 
Reforms are therefore urgently needed and the programme 
launched by the State Department in 200910,11 aims to make a 
number of fundamental changes (see Box 1). 
With this broad background in our mind, we now turn our 
attention to the HKU-SZH.
HKU-SZH – a new model of healthcare in China 
Given the continued urban expansion of Shenzhen and 
the growing demand for medical services in a city with a 
Box 1. Healthcare reforms initiated in 2009.
>  Extension of basic medical insurance, leading towards a 
universal coverage model. 
>  Primary care provision (also known as grass-root health care 
reform) aiming at strengthening the primary care service,19 
thus reducing the present heavy reliance on public hospitals, 
which currently provide almost 90% of services, nearly all of 
which are specialist services.
>  Public hospital reforms aiming at ending excessive drug sales, 
adopting evidence-based practice, and reducing over-investigation, 
over-prescription and over-regulation. (It is hoped that the present 
itemised payment will be replaced by capitation budget or disease-
related budgets in which payment is based on services provided, or 
based on disease specific group, known also as ‘diagnosis resource 
group’.) This packaged ‘form of payment’ will deter the overuse of 
investigations and prescription. Hopefully personal income gain or 
variation based on number of such billable items will cease. 
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population of more than 10 million, the municipal city 
government started planning and building a new ‘state of the 
art’ hospital in 2007, with an investment of GBP 400 million. 
The municipal government and the University of Hong 
Kong (HKU) started discussions in 2009 and a co-operation 
agreement was signed in July 2011. The Li Ka Shing (LKS) 
Medical School of the University of Hong Kong was entrusted 
with the management of this new hospital. In the same year, the 
board of directors for HKU-SZH was appointed. The hospital 
started its phase 1 operation in July 2012, fi ve years after its 
foundation was laid in 2007 (Fig 1). 
The hospital was designed jointly by the US architect TRO 
Jung|Brannen and the Shenzhen City Design and Architecture 
Institute. It occupies a construction area of 367,000 m2 and has 
capacity for 8,000–10,000 outpatient visits per day. There are 
a total of 2000 beds, 650 beds of which are currently in use; 
the number of available beds will increase to 1500 by the end 
of 2015. In addition, the International Medical Centre started 
operating in the autumn of 2013, comprising its own outpatient 
and inpatient facilities with 238 beds when fully open. In the 
current phase 2 stage of development, there are about 2500 
outpatient attendances daily, 250 A&E attendances daily and 
an average of 400 inpatients. There are a total of 36 ‘state of the 
art’ surgical theatres, of which 12 are currently in regular use. 
Approximately 700 operations are carried out each month, 
including major neurosurgery, thoracic surgery and hepatic 
surgery. There is one cardiac catheter laboratory in operation. 
In total, 20 treatment centres are in service or being established, 
including centres for cardiovascular disease, respiratory 
disease, digestive disease, urogenital disease, endocrinology 
and metabolic disease, perinatology, neurology, orthopaedics, 
rehabilitation medicine, oncology, gynaecology, stomatology, ear 
nose and throat, paediatrics, immunology, haematology, plastic 
and reconstructive surgery, intensive care, anaesthesia and 
surgery, and A&E. Further, the hospital aims to establish fully 
fi ve areas of excellence to follow the University of Hong Kong. 
They are oncology, orthopaedics and traumatology, in-vitro 
fertilisation and prenatal diagnosis, cardiovascular disease and 
organ transplantation. The fi rst two areas are fully operational 
and it is expected that the other three areas will be ready in 2015.
The hospital is unique as a public healthcare facility in 
that it is funded by the City of Shenzhen while the managers 
and senior medical staff are employees directly appointed 
by HKU. The mission mandated by the City to the hospital 
is to improve clinical standards based on a clear governance 
structure, to enhance training and education for all staff and 
to initiate clinical and scientifi c research with the aim that the 
Hospital will become fi rst class nationally and well-known 
internationally. To meet the challenges head on, the hospital put 
into practice the following six pioneering initiatives (Box 2).
HKU-SZH: progress so far
Governance
To develop effective clinical governance, the senior hospital 
management team and chiefs of service of each department 
Fig 1. Hong Kong Shenzhen 
Hospital, 2014. 
Box 2. Pioneering initiatives at HKU-SZH hospital.
>  Triage system: primary care (family medicine) first, followed by 
specialist care. 
>  Transparent charging mechanism and finances; zero tolerance 
to ‘red packets’ or any form of grey income, while aspiring to 
the highest form of probity and professionalism. 
>  Patient-centred, team-based clinical management. 
>  Patient relations management, to deal with patient 
complaints or concerns without delay.
>  Hospital-based indemnity, similar to the crown indemnity in 
the NHS system whereby liability rests with the hospital rather 
than the individual doctor.
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have introduced committees for safety and quality, incident 
reporting, research ethics, and complaints, which are all 
new initiatives to China. These efforts have been rewarded 
through accreditation by the Australian Council of Healthcare 
Standards (ACHS) in November 2013, with the hospital being 
the fi rst in China to receive this certifi cation. The hospital was 
commended by the Shenzhen government as the best run joint-
venture hospital and clinic in the city.
Clinical activity 
Within two years of opening, the hospital has developed a full 
range of services. Unlike other Chinese medical institutions, 
which seldom operate a booking system, we have successfully 
introduced outpatient appointments, some 75% of which are 
made either online or by telephone. The on-site family medicine 
clinic service is fully backed up by secondary specialist services, 
almost always offering consultation on the same day. In 
addition, a chronic disease clinic has been set up by the family 
medicine department. These are all considered as new and 
innovative approaches in China. Patient numbers have steadily 
increased across all services with over 2800 OP attendances 
daily, while in medicine, OP number has exceeded 600 per day. 
There is an average of 160 medical in-patients daily. 
Quality indicators 
Some outstanding quality indicators have been achieved by 
HKU-SZH, including being one of the hospitals with the lowest 
use of antibiotics per patient episode in China and the lowest 
wastage of blood products, and having one of the lowest rates of 
drug errors.
Patient relationships 
An achievement commended by the ACHS relates to the 
manner in which the patient relation (PR) department handles 
complaints. Patients dissatisfi ed with services are advised 
to make a complaint either in person or by phone or e-mail. 
Some 90% of complainants receive a reply within 48 hours. 
All are discussed in a weekly meeting chaired by the deputy 
chief executive of administrative affairs, and subsequently 
followed up and action taken. The process is seen to be clear, 
transparent, and professional, thus avoiding many potential 
medical disputes, and the confrontation and violence that 
can result. As in the NHS, the majority of complaints involve 
poor communication, and an analysis of complaints is shared 
with all staff in a forum held every 6 months, so problems 
may be identifi ed and improvements made. The incidence of 
complaints is remarkably low at less than 0.5%.
Commissioning new services 
To commission a new service in a hospital in China is a lengthy 
process. For example, the commissioning of our hospital 
dialysis service20 started in 2012 has involved many new 
government laws, rules and regulations being enacted to plug 
some past ‘loopholes’. The tender and purchase of haemodialysis 
equipment, their installation, inspection and approval for 
operation, the staffi ng of the service and the processes for 
training, quality control and audit are outlined in Box 3. 
HKU-SZH: a new model of education and training 
In China, there is so far no structured, postgraduate training 
curriculum for doctors or nurses, nor are there clear processes 
for assessment or promotion in place. The training varies from 
city to city and province to province. The value of scientifi c 
contributions in the form of publications is often overplayed, 
regardless of merit, and plays an undue part in assessment 
for promotion. Intermediate and more advanced written 
examinations are used in different provinces for different 
specialties, as part of the requirement for promotion, but these 
are not standardised. Many doctors will pursue the gaining of a 
doctorate as a means for promotion rather than for intellectual 
satisfaction or enrichment. 
Within the HKU-SZH, a learning environment where 
interactive debate and discussion are encouraged and valued 
is being introduced. In addition to twice-weekly professorial 
ward rounds undertaken by the HKU faculty staff, there is a 
fortnightly hospital grand round and a weekly Department 
of Medicine meeting. In the fi rst two years of operation, the 
Department of Medicine held two CME-accredited courses in 
general internal medicine in addition to other specialty CME 
courses, and a course on dialysis with a practical demonstration 
is also planned. Doctors and nurses are given the chance to 
attach to various university departments for observation, and 
free places are made available for the HKU-SZH staff to attend 
medical meetings in the Queen Mary Hospital, HKU, and vice 
versa. In the UK, links are established with the Royal College of 
Physicians of Edinburgh using international web-streaming.
HKU-SZH: clinical outcomes assessment
Recently, the HKU-SZH dialysis centre was among 14 successful 
applications from the hospital to receive a grant provided by 
the Shenzhen Science and Technology Institute through open 
competition. The grant is given to fi nd out whether a new 
model of managing haemolysis patients enhances treatment 
outcomes and quality of life. The hospital is also striking out to 
become an accredited training centre for family medicine and 
other specialties. We are currently introducing a structured 
curriculum for higher medical training akin to the one used 
by the Hong Kong College of Physicians. We are also adopting 
assessment tools based on the case-based discussion, mini-
clinical evaluation exercise and direct observation of procedure 
assessments used by the Joint Royal Colleges of Physicians 
Training Board. 
The Future Hospital Commission: relevance to 
HKU-SZH? 
The NHS has long held a role in leading and shaping the 
provision of healthcare, but in a number of areas China is 
working differently; both systems may learn and benefi t from 
each other in a number of areas. 
One such area is recognition of the potential role of primary 
care and generalists. The importance of primary care, or the 
lack of it, is nowhere better illustrated than in the metropolitan 
areas of China. Where functional primary care centres exist, 
they are usually privately run and serve largely non-Chinese-
speaking expatriates from overseas. Moreover, the prevailing 
attitude among Chinese people is to insist on visiting hospital 
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specialists even for minor illnesses. In the UK, where primary 
care is established, we suggest secondary care must provide a 
supporting role and not become decoupled from it, as is the 
case in China. On clinical and economic grounds, chronic 
disease management should be based in primary care. At HKU-
SZH, we have developed a comprehensive family medicine 
service and have geared towards training generalists to provide 
coordinated care for an ageing population.
Second, waiting times in China for consultation and 
treatment are kept to a minimum or else the patients seek 
immediate attention elsewhere, taking their source of funding 
with them. Consequently, access to nearly all specialist services 
can be obtained within days. Patients are truly making choices 
regarding where and when and by whom their treatment is 
delivered. This advantage is countered by the phenomenon of 
doctor or hospital ‘shopping’, and associated waste of resources. 
In the UK, patients are generally more passive. However, overall 
the current NHS debate about waiting times should encourage 
patients to be more proactive, like their Chinese counterparts, 
in making healthcare choices.
Third, the majority of doctors and nurses at HKU-SZH are 
extremely dedicated and committed to the hospital and all 
work towards a common goal. Overtime is not uncommon, and 
locums are not required. All mandatory lectures and exercises 
such as fi re drills are well attended by staff from all sectors. It 
is a normal practice for educational seminars and forums to be 
held on weekends to minimise the impact on regular services. 
Sickness leave is less than 1%.
Fourth, handovers and medical records in China are afforded 
great emphasis. The quality of case notes is one of the main 
determinants of the class and the grade of a hospital. Clinical 
notes are audited on a regular and frequent basis for their 
accuracy, completeness and timeliness by a dedicated hospital 
medical record department. All patients are given a detailed 
copy of summary at the time of discharge, akin to a discharge 
letter to the GP in the UK. Diagnoses are ICD coded in the 
discharge summary. All notes and summaries are typed by the 
resident doctor and must be checked and signed by another 
doctor. Secretaries are assigned to departments rather than to 
individual consultants. Each morning, there is a structured 
handover on each ward where the night staff and resident on-
call report on all admissions and incidents from the previous 
night. The handover is attended by all ward doctors and nurses. 
All out-of-hours admissions and incidents are documented and 
signed in a handover book. 
Fifth, in China there are strict rules that all urgent 
consultations must be seen within 30 minutes and, for non-
urgent specialist consultation, within 24 hours of request. If 
an inpatient diagnosis is unclear after three working days, 
the attending clinicians are urged to call a multidisciplinary 
team meeting involving relevant clinical and diagnostic 
disciplines to discuss the case further, and these deliberations 
Box 3. Commissioning a new dialysis service.
>  Planning. A need for the dialysis centre and its equipment must be demonstrated and an application filed with the City. Once the 
application is approved, then a set tender process must be followed; the process is very protracted.
>  Installation, inspection and approval. The first Chinese Standard of Operation Procedure (SOP) on dialysis was published in 
2010.21 It refers to the standard of the facility, the qualifications of the staff, quality assurance, and compliance with international 
standards and guidelines. All new dialysis centres must comply with and satisfy the implementation guidelines before a license for 
their operation is granted. An on-site inspection is performed by clinical experts and a representative from the health authority to 
decide if all the requirements of the SOP have been met.
>  Staffing. Since 2010, all dialysis staff must possess the relevant certificates to work in a dialysis centre. Unlike in the UK, where 
increasingly nurses are given an extended or specialist role, nurses in China are assigned to a hospital department according to its 
needs; additional training is therefore often required when they are given a new assignment.
>  Information and education. Patient information and education are often inadequate in China. Guidelines are poorly complied with 
by patients and clinicians alike. For this, free staff and patient education forums have been organised in HKU-SZH Hospital to 
highlight various diseases, their prevention and treatment. Nurses are given more responsibilities and opportunities to develop their 
own talents and build up their clinical expertise. Patients are increasingly taking an interest in their treatment.
>  Social insurance payment. In China, all medical costs are contained in an official pricing book and dialysis is paid for per session. 
Despite social insurance cover, dialysis is not free in full, and even those patients entitled to receive it need to make a co-payment. 
Hospitals must receive approval from the Insurance Bureau as a designated haemodialysis centre eligible to apply and receive 
insurance payments before they get reimbursed. Again the application and its ultimate approval take time and effort.
>  Guidelines, pathways and quality standards. In the NHS and among nephrologists in the UK, comparative audit and self-reporting 
to the Renal Registry are taken for granted and recognised as a scheme designed to improve quality of care. In China there is no 
regulatory requirement to report dialysis outcomes. The Chinese SOP 2010 on dialysis refers to international guidelines such as 
KDOQI, and staff receive education on this, but with no enforcement. The guideline is referred to only when there is a critical incident. 
There is a lack of cooperation and mutual trust between different dialysis centres. Within our dialysis unit, we have put into place an 
environment of safe practice, clinical governance and quality assurance linked to dialysis therapy as demanded by international 
standards and audit cycles. Clinical pathways are being introduced in China by the government’s desire to cap escalating medical 
cost. But at HKU-SZH we believe audits and clinical pathways should be developed and led by qualified doctors and the healthcare 
team. For example, at HKU-SZH, vascular catheterisation must only be undertaken under ultrasound guidance or screening, which is 
not the case in many other units. 
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are fully documented in the notes and in a record book. 
Similarly, a mandatory mortality meeting must be held within 
seven working days of the death of a patient to provide an 
opportunity to fully review the case and identify learning 
points for the future. The meeting summary must be signed 
and kept in the mortality record book. 
Conclusion
Healthcare provision in China is a free market; patients are 
paying clients and many doctors feel that they need to do 
what patients tell them to keep them. By contrast, the NHS 
is sustained on mutual trust and respect between doctors 
and patients. At HKU-SZH, we believe we can gain the trust 
of Chinese patients and serve them better by being honest, 
professional and empathetic. 
The gap between China and the West is closing as more 
collaboration is taking place nationally and globally. 
These exchanges are already bringing benefi ts to patients 
and improving care. By developing health education, by 
promoting health, primary prevention and family medicine, 
by introducing structured training, assessment and appraisal 
systems and making promotion transparent, and by promoting 
mutual respect between doctor and patient, healthcare reforms 
in China will be effective and economically sustainable. Thus, 
in 2009 the Chinese government proposed an investment of 
GBP 85 billion (US$138 billion) in healthcare reform for 2009–
20111–4 and holds out a promise of equal access and universal 
coverage by 2020 for its 1.39 billion people.12,19 It is another 
‘Great Wall’ in the making, but unlike the original Great Wall, 
built to keep the northern invaders out of China, these reforms 
are looking beyond and welcome new ideas and reforms. For 
these reasons, we are immensely privileged and proud to take 
part in this mission. ■
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